BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21908737)

  • 1. Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity.
    Housley WJ; Adams CO; Vang AG; Brocke S; Nichols FC; LaCombe M; Rajan TV; Clark RB
    J Immunol; 2011 Oct; 187(8):4161-9. PubMed ID: 21908737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN22 Acts in a Cell Intrinsic Manner to Restrict the Proliferation and Differentiation of T Cells Following Antibody Lymphodepletion.
    Knipper JA; Wright D; Cope AP; Malissen B; Zamoyska R
    Front Immunol; 2020; 11():52. PubMed ID: 32047502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.
    Dunn SE; Ousman SS; Sobel RA; Zuniga L; Baranzini SE; Youssef S; Crowell A; Loh J; Oksenberg J; Steinman L
    J Exp Med; 2007 Feb; 204(2):321-30. PubMed ID: 17261635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.
    Winstead CJ; Fraser JM; Khoruts A
    J Immunol; 2008 Jun; 180(11):7305-17. PubMed ID: 18490730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis.
    Soller M; Tautenhahn A; Brüne B; Zacharowski K; John S; Link H; von Knethen A
    J Leukoc Biol; 2006 Jan; 79(1):235-43. PubMed ID: 16380602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions.
    Le Saout C; Mennechet S; Taylor N; Hernandez J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19414-9. PubMed ID: 19033460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.
    Calzascia T; Pellegrini M; Lin A; Garza KM; Elford AR; Shahinian A; Ohashi PS; Mak TW
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2999-3004. PubMed ID: 18287017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct regulation of autoreactive CD4 T cell expansion by interleukin-4 under conditions of lymphopenia.
    Hill NJ; Stotland AB; Sarvetnick NE
    J Leukoc Biol; 2007 Mar; 81(3):757-65. PubMed ID: 17164429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD27 Promotes CD4
    Remedios KA; Meyer L; Zirak B; Pauli ML; Truong HA; Boda D; Rosenblum MD
    J Immunol; 2019 Aug; 203(3):639-646. PubMed ID: 31209102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis.
    Hontecillas R; Bassaganya-Riera J
    J Immunol; 2007 Mar; 178(5):2940-9. PubMed ID: 17312139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor γ deficiency in T cells accelerates chronic rejection by influencing the differentiation of CD4+ T cells and alternatively activated macrophages.
    Huang X; Ren L; Ye P; Cheng C; Wu J; Wang S; Sun Y; Liu Z; Xie A; Xia J
    PLoS One; 2014; 9(11):e112953. PubMed ID: 25383620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms.
    Wohlfert EA; Nichols FC; Nevius E; Clark RB
    J Immunol; 2007 Apr; 178(7):4129-35. PubMed ID: 17371968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy.
    Klotz L; Dani I; Edenhofer F; Nolden L; Evert B; Paul B; Kolanus W; Klockgether T; Knolle P; Diehl L
    J Immunol; 2007 Feb; 178(4):2122-31. PubMed ID: 17277116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity.
    Carbo A; Hontecillas R; Kronsteiner B; Viladomiu M; Pedragosa M; Lu P; Philipson CW; Hoops S; Marathe M; Eubank S; Bisset K; Wendelsdorf K; Jarrah A; Mei Y; Bassaganya-Riera J
    PLoS Comput Biol; 2013 Apr; 9(4):e1003027. PubMed ID: 23592971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.
    Guri AJ; Mohapatra SK; Horne WT; Hontecillas R; Bassaganya-Riera J
    BMC Gastroenterol; 2010 Jun; 10():60. PubMed ID: 20537136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.
    Zhao W; Beers DR; Liao B; Henkel JS; Appel SH
    Neurobiol Dis; 2012 Dec; 48(3):418-28. PubMed ID: 22820142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARgamma regulates retinoic acid-mediated DC induction of Tregs.
    Housley WJ; O'Conor CA; Nichols F; Puddington L; Lingenheld EG; Zhu L; Clark RB
    J Leukoc Biol; 2009 Aug; 86(2):293-301. PubMed ID: 19401386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity.
    Ploix C; Lo D; Carson MJ
    J Immunol; 2001 Dec; 167(12):6724-30. PubMed ID: 11739486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.